Precision Fc remodeling via glycosylation-competent CHO display enables ultra-selective FcγRIIIa targeting and enhanced antitumor activity

Abstract Background Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-type IgG1 Fc typically elicits suboptimal NK cell–mediated antibody-dependent cellular cytotoxicity (ADCC), necessitating Fc engineering to enhance activating FcγR engagement...

Descripció completa

Dades bibliogràfiques

Autors principals:	Migyeong Jo, Suyeon Kim, Sanghwan Ko, Munsu Kyung, Seunghyeon Lee, Woo Hyung Ko, Wonju Lee, Sang Taek Jung
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-04-01
Col·lecció:	Journal of Biological Engineering
Matèries:	Therapeutic IgG antibody FcγRIIIa CHO-based mammalian display Fc engineering Target cell lysis
Accés en línia:	https://doi.org/10.1186/s13036-026-00671-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!